Radical surgery for mesothelioma

w1 Peto J, Seidman H, Selikoff IJ. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer 1982;45:124-35.

w2 Health and Safety Executive. Amendment to the control of asbestos at work regulations 1987 and ACOP regulatory impact assessment. www.hse.gov.uk/ria/chemical/ria-176.pdf (accessed 28 Oct 2003).

w3 Health and Safety Executive. Asbestos. www.hse.gov.uk/asbestos/index.htm (accessed 28 Oct 2003).

w4 National Occupational Health and Safety Commission. Australian mesothelioma register report, 2001. www.nohsc.gov.au/Statistics/mesothelioma_01.htm (accessed 28 Oct 2003).

w5 Parker PM, ed. The 2003 world market forecasts for imported asbestos. San Diego, CA: Icon, 2003. www.icongrouponline.com/browse/WorldTS/0597852146.html (accessed 28 Oct 2003).

w6 Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L,et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122:788-95.

w7 Jaklitsch MT, Grondin SC, Sugarbaker DJ. Treatment of malignant mesothelioma. World J Surg 2001;25:210-7.

w8 Maggi G, Casadio C, Cianci R, Rena O, Ruffini E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2001;19:346-50.

w9 Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002;22:298-305.